Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy

BMC Veterinary Research

Table 1 Descriptive Values for Pimobendan Treatment Group

	Baseline	Post-pimobendan	P value
Murmur² [(median grade (IQR)]	3 (2,4)	3 (3,4)	0.13
HR¹ (mean bpm ± SD)	192.7 ± 29.76	198.5 ± 24.09	0.29
Thickest wall segment¹ (mean mm ± SD)	7.28 ± 0.844	6.9 ± 0.853	0.89
Systolic blood pressure² [median mmHg (IQR)]	125 (109, 130)	127 (113.5, 136.5)	0.36
LAlax¹ (mean mm ± SD)	14.7 ± 2.66	15.15 ± 2.66 1.2)	0.20
LVIDd¹ (mean mm ± SD)	14.18 ± 1.38	14.51 ± 2.22	0.37

¹Paired T test
²Wilcoxon matched-pairs signed rank test
IQR, interquartile range; HR, heart rate; bpm, beats per minute; SD, standard deviation; LA, left atrium

ISSN: 1746-6148